These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17293025)

  • 1. The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement.
    Hashim H; Elhilali M; Bjerklund Johansen TE; Abrams P;
    Eur Urol; 2007 Oct; 52(4):1186-93. PubMed ID: 17293025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial comment on: The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement.
    Perrin P
    Eur Urol; 2007 Oct; 52(4):1194. PubMed ID: 17293027
    [No Abstract]   [Full Text] [Related]  

  • 3. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
    Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment on: The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement.
    Meuleman EJ
    Eur Urol; 2007 Oct; 52(4):1193-4. PubMed ID: 17293024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic value of urodynamic parameters multianalysis in the evaluation of bladder outlet obstruction resulting from benign prostatic hyperplasia].
    Liang YY; Cao MX; Dai YP; Liang WJ; Zheng KL
    Zhonghua Nan Ke Xue; 2006 Sep; 12(9):818-21. PubMed ID: 17009536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate.
    Paick JS; Um JM; Kwak C; Kim SW; Ku JH
    Urology; 2007 May; 69(5):859-63. PubMed ID: 17482922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressure-flow studies in patients with benign prostatic hyperplasia: a study comparing suprapubic and transurethral methods.
    Zhao SC; Zheng SB; Tan WL; Zhang P; Qi H
    Asian J Androl; 2006 Nov; 8(6):731-5. PubMed ID: 16855778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of the reproducibility and applicability of the condom catheter method for noninvasive urodynamics in two Dutch centers.
    Huang Foen Chung JW; Spigt MG; Knottnerus JA; van Mastrigt R
    Urol Int; 2008; 81(2):139-48. PubMed ID: 18758210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging the maximum flow rate: a new index of voiding dysfunction in men with benign prostatic enlargement.
    Valentini FA; Nelson PP; Besson GR; Zimmern PE
    BJU Int; 2008 Apr; 101(8):995-9. PubMed ID: 18241248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Applying bladder outlet obstruction number to predict bladder outlet obstruction of benign prostatic hyperplasia].
    Zhang P; Wu ZJ; Yang Y; Zhang XD
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1156-9. PubMed ID: 19094679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual fraction as a parameter to predict bladder outlet obstruction in men with lower urinary tract symptoms.
    Ku JH; Cho SY; Oh SJ
    Int J Urol; 2009 Sep; 16(9):739-44. PubMed ID: 19659551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.
    Dib PT; Trigo-Rocha F; Gomes CM; Srougi M
    Urol Int; 2008; 80(4):378-82. PubMed ID: 18587248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of retrospective quality control on pressure-flow data with computer-based urodynamic systems from men with benign prostatic hyperplasia.
    Liao LM; Schaefer W
    Asian J Androl; 2007 Nov; 9(6):771-80. PubMed ID: 17968462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
    J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of transurethral catheterization on uroflow rate in the pressure-flow study of patients with benign prostatic hyperplasia].
    Zhao SC; Zheng SB; Tan WL; Mao XM; Zhang P; Huang ZM; Zhang HJ; Zuo Y
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):710-2. PubMed ID: 17918710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.